Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 陈德章教授 (肿瘤学系) |
| 马碧如教授 (肿瘤学系) |
全文
| 数位物件识别号 (DOI) http://dx.doi.org/10.1016/j.hoc.2008.08.012 |
引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/24WOS source URL
其它资讯
摘要Despite being potentially curable at an early stage, more than 50% of patients who have nasopharyngeal carcinoma present with advanced locoregional disease, which results in a poor prognosis. This article discusses key advancements in the management of nasopharyngeal cancer, including the incorporation of concurrent chemoradiotherapy, new radiotherapy delivery techniques in the form of conformal and intensity-modulated radiotherapy, and salvage options for locoregional recurrence. New cytotoxic and targeted therapies that have resulted in improved survival in the metastatic setting are also described. The use of Epstein-Barr virus DNA for the prognostication and monitoring of nasopharyngeal cancer and the role of new diagnostic imaging techniques are also discussed.
着者Loong HH, Ma BB, Chan AT
期刊名称Hematology/Oncology Clinics of North America
出版年份2008
月份12
日期1
卷号22
期次6
出版社WB Saunders
页次1267 - +
国际标準期刊号0889-8588
语言英式英语
关键词Chemoradiotherapy; Chemotherapy; IMRT; Nasopharyngeal cancer; Plasma EBV-DNA
Web of Science 学科类别Hematology; HEMATOLOGY; Oncology; ONCOLOGY
